Literature DB >> 1324142

Gastrointestinal transit times of radiolabeled meal in progressive systemic sclerosis.

J L Madsen1, L Hendel.   

Abstract

Gastrointestinal transit times were measured in 12 patients with progressive systemic sclerosis. The CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) was found in all patients. None of the patients reported complaints referable to specific gastric, small intestinal, or colonic involvement. The patient group had an increased mean gastric emptying time of 99mTc-labeled cellulose fiber when compared with 16 healthy controls [1.17 (0.89-1.38) hr [median (range)] vs 0.84 (0.56-1.88) hr; P less than 0.02], whereas mean gastric emptying time of 2- to 3-mm 111In-labeled plastic particles was unaffected [1.86 (0.99-2.74) hr vs 1.50 (0.92-2.51) hr; NS]. No difference was observed in mean small intestinal transit time of cellulose fiber [4.33 (0.50-7.04) hr vs 3.74 (2.09-7.59) hr; NS] or plastic particles [4.21 (2.00-6.25) hr vs 3.53 (1.50-6.70) hr; NS] between patients and controls. The patient group had an increased mean colonic transit time of plastic particles [47 (24-116) hr vs 29 (18-46) hr; P less than 0.01]. These findings suggest that asymptomatic delay in gastric emptying and colonic transit is frequent in patients with progressive systemic sclerosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324142     DOI: 10.1007/bf01296011

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Successful treatment of gastroparesis with erythromycin in a patient with progressive systemic sclerosis.

Authors:  J S Dull; J P Raufman; M D Zakai; A Strashun; E W Straus
Journal:  Am J Med       Date:  1990-10       Impact factor: 4.965

2.  The esophageal and small-bowel manifestations of progressive systemic sclerosis. A pathophysiologic explanation of the roentgenographic signs.

Authors:  W W Olmsted; J E Madewell
Journal:  Gastrointest Radiol       Date:  1976

3.  Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis.

Authors:  M P Greydanus; M Camilleri
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

4.  Rectosigmoid motility and myoelectric activity in progressive systemic sclerosis.

Authors:  W E Whitehead; G Taitelbaum; F M Wigley; M M Schuster
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

5.  Esophageal manometry and pH-probe monitoring in the evaluation of gastroesophageal reflux in patients with progressive systemic sclerosis.

Authors:  P Stentoft; L Hendel; S Aggestrup
Journal:  Scand J Gastroenterol       Date:  1987-05       Impact factor: 2.423

6.  Effects of cisapride on gastrointestinal transit in healthy humans.

Authors:  J L Madsen
Journal:  Dig Dis Sci       Date:  1990-12       Impact factor: 3.199

7.  Gastrointestinal function in patients with progressive systemic sclerosis.

Authors:  A Akesson; B Akesson; T Gustafson; F Wollheim
Journal:  Clin Rheumatol       Date:  1985-12       Impact factor: 2.980

8.  The gastrointestinal manifestations of scleroderma: pathogenesis and management.

Authors:  S Cohen
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

9.  Comparative esophageal and anorectal motility in scleroderma.

Authors:  J Hamel-Roy; G Devroede; P Arhan; L Tétreault; A Duranceau; H A Ménard
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

10.  Abnormal colonic motility in progressive systemic sclerosis.

Authors:  W M Battle; W J Snape; S Wright; M A Sullivan; S Cohen; A Meyers; R Tuthill
Journal:  Ann Intern Med       Date:  1981-06       Impact factor: 25.391

View more
  9 in total

Review 1.  Pharmacotherapy of systemic sclerosis.

Authors:  Arnold E Postlethwaite; L Jeff Harris; Syed H Raza; Swapna Kodura; Titilola Akhigbe
Journal:  Expert Opin Pharmacother       Date:  2010-04       Impact factor: 3.889

2.  Gastric dysmotility after liquid bolus ingestion in systemic sclerosis: an ultrasonographic study.

Authors:  Franco Cozzi; Giancarlo Parisi; Luca Ciprian; Arianna Bullo; Silvia Cardarelli; Michela Rizzo; Paolo Sfriso; Leonardo Punzi
Journal:  Rheumatol Int       Date:  2011-01-22       Impact factor: 2.631

3.  Proximal stomach function in systemic sclerosis: relationship with autonomic nerve function.

Authors:  P Iovino; G Valentini; C Ciacci; A De Luca; F Tremolaterra; F Sabbatini; E Tirri; G Mazzacca
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

4.  Intestinal perforation. A common complication of scleroderma.

Authors:  E C Ebert; F M Ruggiero; J R Seibold
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

Review 5.  Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis.

Authors:  Daniel E Furst; Yolanda Braun-Moscovic; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

6.  Colon involvement in systemic sclerosis: clinical-radiological correlations.

Authors:  M Govoni; M Muccinelli; P Panicali; R La Corte; P Nuccio Scutellari; C Orzincolo; P Pazzi; F Trotta
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

7.  Transcutaneous electrical nerve stimulation (TENS) improves upper GI symptoms and balances the sympathovagal activity in scleroderma patients.

Authors:  Hanaa Sallam; Terry A McNearney; Dipti Doshi; J D Z Chen
Journal:  Dig Dis Sci       Date:  2007-03-20       Impact factor: 3.487

8.  Gastrointestinal Manifestations of Systemic Sclerosis.

Authors:  Isabel M McFarlane; Manjeet S Bhamra; Alexandra Kreps; Sadat Iqbal; Firas Al-Ani; Carla Saladini-Aponte; Christon Grant; Soberjot Singh; Khalid Awwal; Kristaq Koci; Yair Saperstein; Fray M Arroyo-Mercado; Derek B Laskar; Purna Atluri
Journal:  Rheumatology (Sunnyvale)       Date:  2018-03-30

9.  Slow Colonic Transit in Systemic Sclerosis: An Objective Assessment of Risk Factors and Clinical Phenotype.

Authors:  Jenice X Cheah; Jamie Perin; Elizabeth R Volkmann; Laura K Hummers; Pankaj J Pasricha; Fredrick M Wigley; Zsuzsanna H McMahan
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-08-09       Impact factor: 5.178

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.